← Back to Search

Nocturnal Oxygen for Hypoxia

N/A
Waitlist Available
Led By Trishul Siddharthan, MD
Research Sponsored by University of Miami
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Chronic respiratory condition resting Sat < 95% off oxygen
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 10 hours
Awards & highlights

Study Summary

This trial looks at how changes in oxygen levels affect the heart's electrical activity in people with and without oxygen needs.

Who is the study for?
This trial is for individuals who can consent and have a chronic respiratory condition with oxygen saturation below 95% when not using supplemental oxygen. It's not for those with severe obesity, recent heart issues, uncontrolled medical conditions like angina or high blood pressure, cancer, or active major depression.Check my eligibility
What is being tested?
The study is looking at how varying oxygen levels during the night affect heart electrical activity in people with chronic lung problems who do and don't use nighttime oxygen.See study design
What are the potential side effects?
While the trial involves nocturnal oxygen therapy which typically has minimal side effects, potential risks may include dry or bloody nose, morning headaches, and discomfort from wearing the mask.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My oxygen levels fall below 95% when I'm not using supplemental oxygen.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 10 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 10 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
QT Variability Index
Secondary outcome measures
Heart rate
QT-RR interval

Trial Design

2Treatment groups
Active Control
Group I: Healthy Control GroupActive Control1 Intervention
Individuals without lung disease will receive oxygen for a period of four hours
Group II: Nocturnal hypoxemia groupActive Control1 Intervention
Individuals with lung disease will receive oxygen for a period of four hours

Find a Location

Who is running the clinical trial?

University of MiamiLead Sponsor
897 Previous Clinical Trials
409,190 Total Patients Enrolled
4 Trials studying Hypoxia
566 Patients Enrolled for Hypoxia
Trishul Siddharthan, MDPrincipal InvestigatorUniversity of Miami
1 Previous Clinical Trials
100 Total Patients Enrolled

Media Library

Healthy Control Group Clinical Trial Eligibility Overview. Trial Name: NCT05606406 — N/A
Hypoxia Research Study Groups: Healthy Control Group, Nocturnal hypoxemia group
Hypoxia Clinical Trial 2023: Healthy Control Group Highlights & Side Effects. Trial Name: NCT05606406 — N/A
Healthy Control Group 2023 Treatment Timeline for Medical Study. Trial Name: NCT05606406 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what demographic does this investigation extend?

"In order to be accepted into this medical trial, applicants must possess anoxia and have reached the age of legal responsibility but not exceeded 70 years. This research is currently recruiting around seventy individuals."

Answered by AI

Are seniors being accepted as participants in this experiment?

"The eligibility requirements for this trial necessitate that all participants must be between 18 and 70 years old."

Answered by AI

Is enrollment open for this research endeavor?

"As evidenced on clinicaltrials.gov, enrollment for this specific study has ceased as of the last edit to its page which was made November 1st 2022. However, there are still 405 other studies that are actively recruiting at present time."

Answered by AI
~47 spots leftby Dec 2025